Oral anticoagulants reassessed.
作者信息
Poller L
出版信息
Br Med J (Clin Res Ed). 1982 May 15;284(6327):1425-6. doi: 10.1136/bmj.284.6327.1425.
Abstract
摘要
相似文献
1
Oral anticoagulants reassessed.口服抗凝剂重新评估。
Br Med J (Clin Res Ed). 1982 May 15;284(6327):1425-6. doi: 10.1136/bmj.284.6327.1425.
2
Control of oral anticoagulants by the prothrombin time: a plea for uniformity.通过凝血酶原时间控制口服抗凝剂：呼吁统一标准。
Med J Aust. 1978 Nov 4;2(10):459-61. doi: 10.5694/j.1326-5377.1978.tb131641.x.
3
Questions and answers on prothrombin time standardisation in oral anticoagulant control.口服抗凝治疗中凝血酶原时间标准化的问答
Thromb Haemost. 1985 Aug 30;54(2):515-7.
4
The use of reference plasmas in the control of oral anticoagulant therapy.参比血浆在口服抗凝治疗控制中的应用。
Scand J Haematol Suppl. 1980;37:21-33. doi: 10.1111/j.1600-0609.1980.tb01339.x.
5
6
Laboratory control of oral anticoagulants.口服抗凝剂的实验室监测
Br Med J (Clin Res Ed). 1987 May 9;294(6581):1184. doi: 10.1136/bmj.294.6581.1184.
7
Thromboplastin and oral anticoagulant control.凝血活酶与口服抗凝剂控制
Br J Haematol. 1987 May;66(1):1-4.
8
ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.国际血液学标准化委员会/国际血栓与止血学会关于口服抗凝治疗中凝血酶原时间报告的建议。
Clin Chim Acta. 1985 Mar 15;146(2-3):229H-233H.
9
ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.国际血液学标准化委员会/国际血栓与止血学会关于口服抗凝治疗中凝血酶原时间报告的建议。
Acta Haematol. 1984;72(6):405-7. doi: 10.1159/000206427.
10
[Control of the treatment with oral anticoagulants and prothrombin time].[口服抗凝剂治疗的控制与凝血酶原时间]
Rev Med Chil. 1991 Oct;119(10):1160-4.
引用本文的文献
1
Problems with anticoagulants.抗凝剂的问题。
Br Med J (Clin Res Ed). 1982 Jul 24;285(6337):242-3. doi: 10.1136/bmj.285.6337.242.
本文引用的文献
1
Anticoagulants in acute myocardial infarction.
Lancet. 1961 Aug 12;2(7198):327-31. doi: 10.1016/s0140-6736(61)90629-8.
2
An evaluation of chromogenic substrates in the control of oral anticoagulant therapy.
Br J Haematol. 1981 Feb;47(2):307-18. doi: 10.1111/j.1365-2141.1981.tb02791.x.
3
Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.皮下注射调整剂量肝素与华法林钠在静脉血栓形成长期治疗中的比较
N Engl J Med. 1982 Jan 28;306(4):189-94. doi: 10.1056/NEJM198201283060401.
4
Therapeutic control of anticoagulant treatment.抗凝治疗的治疗性控制
Br Med J (Clin Res Ed). 1982 Mar 6;284(6317):702-4. doi: 10.1136/bmj.284.6317.702.
5
Anticoagulants in coronary heart disease--retrospect and prospect.冠心病中的抗凝剂——回顾与展望
Lancet. 1981 Jan 31;1(8214):257-62. doi: 10.1016/s0140-6736(81)92095-x.
6
A 7-year analysis of haemorrhage in patients on long-term anticoagulant treatment.长期抗凝治疗患者出血情况的7年分析。
Br Heart J. 1979 Aug;42(2):128-32. doi: 10.1136/hrt.42.2.128.
7
Quality control trials of prothrombin time: an assessment of the performance in serial studies.凝血酶原时间的质量控制试验：系列研究中的性能评估
J Clin Pathol. 1979 Mar;32(3):251-3. doi: 10.1136/jcp.32.3.251.
8
Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis.
N Engl J Med. 1979 Oct 18;301(16):855-8. doi: 10.1056/NEJM197910183011602.
9
Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis.英国比较凝血活酶对照口服抗凝剂与低剂量肝素预防深静脉血栓形成的研究
Br Med J. 1978 Feb 4;1(6108):272-4. doi: 10.1136/bmj.1.6108.272.
10
Hypercoagulability.高凝状态
Semin Hematol. 1977 Oct;14(4):409-25.
Zotero 插件